No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Dexamethasone improved isatuximab efficacy in patients with relapsed/refractory multiple myeloma

byKathleen Lau

March 26, 2021

in StudyGraphics

Poor sleep efficiency associated with major adverse cardiovascular events

RelatedReports

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Testosterone replacement in male cancer survivors helps improve body composition

Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 12, 2026

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

2 Minute Medicine Rewind March 29, 2021

Smoking during pregnancy associated with aerobic fitness of children

Smoking and cardiovascular disease may explain sex-related differences in mortality

Age dependent associations of risk factors with heart failure

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports